Literature DB >> 13722333

Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

S DEVADATTA, R H ANDREWS, J H ANGEL, A L BHATIA, W FOX, B JANARDHANAM, S RADHAKRISHNA, C V RAMAKRISHNAN, T V SUBBAIAH, S VELU.   

Abstract

A controlled comparison by the Tuberculosis Chemotherapy Centre, Madras, of the merits of home as compared with sanatorium treatment for pulmonary tuberculosis showed that, at the end of a year of chemotherapy with isoniazid plus p-aminosalicylic acid (PAS), the response of the home patients closely approached that of the sanatorium patients. The present report reviews the progress of those patients in the controlled comparison whose disease had attained bacteriological quiescence by the end of the year of combined chemotherapy. During the second year, half of the patients received further chemotherapy, with isoniazid alone, and half received a placebo, calcium gluconate. During the third year, half of those who were treated with isoniazid in the second year and whose disease remained quiescent continued to receive that drug and all the remaining patients with quiescent disease received the placebo. In the second and third years all the patients were treated at home and administered the medicaments to themselves.It has been concluded from this follow-up study that in the second and third years there was relatively little difference between the progress of the patients whose disease attained quiescence following a year of domiciliary treatment with isoniazid plus PAS and that of those whose disease attained quiescence following a year's treatment with the same drugs in sanatorium; that a second or third year of further treatment with isoniazid alone gave no better results than a year of combined chemotherapy, followed by careful observation of the patient and further chemotherapy if relapse occurred; and that the relapse rate among the patients with residual cavitation at the end of the year of combined chemotherapy was slightly higher than that among the patients with no residual cavitation at the end of the first year.

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1961        PMID: 13722333      PMCID: PMC2555497     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  19 in total

1.  Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S VELU; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; C V RAMAKRISHNAN; J B SELKON; P R SOMASUNDARAM; T V SUBBAIAH
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

2.  Relapse rate in a two-to eleven-year follow-up study of patients with pulmonary tuberculosis treated with and without anti-microbials and discharged from 1946 through 1955.

Authors:  E LOW
Journal:  Am Rev Tuberc       Date:  1959-05

3.  The late results of prolonged multiple-drug therapy for pulmonary tuberculosis.

Authors:  J W RALEIGH
Journal:  Am Rev Tuberc       Date:  1957-10

4.  The fate of the patient with persistent cavitation and noninfectious sputum ("open-negative") after discharge from the hospital.

Authors:  R F CORPE; F A BLALOCK
Journal:  Am Rev Tuberc       Date:  1958-05

5.  On omitting PAS.

Authors:  N WYNN-WILLIAMS; M ARRIS
Journal:  Tubercle       Date:  1958-06

6.  Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953.

Authors:  J D ROSS; N W HORNE; I W GRANT; J W CROFTON
Journal:  Br Med J       Date:  1958-02-01

7.  A five-year assessment of patients in a controlled trial of streptomycin, para-aminosalicylic acid, and streptomycin plus para-aminosalicylic acid, in pulmonary tuberculosis.

Authors:  W FOX; I SUTHERLAND
Journal:  Q J Med       Date:  1956-04

8.  A five-year assessment of patients in a controlled trial of streptomycin in pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND; M DANIELS
Journal:  Q J Med       Date:  1954-07

9.  Influence of segregation to tuberculous patients for one year on the attack rate of tuberculosis in a 2-year period in close family contacts in South India.

Authors:  C V RAMAKRISHNAN; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; P R SOMASUNDARAM; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

10.  A comparison of the sensitivity to p-aminosalicylic acid of tubercle bacilli from South Indian and British patients.

Authors:  J B SELKON; T V SUBBAIAH; A L BHATIA; S RADHAKRISHNA; D A MITCHISON
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

View more
  12 in total

1.  REALISTIC CHEMOTHERAPEUTIC POLICIES FOR TUBERCULOSIS IN THE DEVELOPING COUNTRIES.

Authors:  W FOX
Journal:  Br Med J       Date:  1964-01-18

2.  Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.

Authors:  S VELU; R H ANDREWS; J H ANGEL; S DEVADATTA; W FOX; P R GANGADHARAM; A S NARAYANA; C V RAMAKRISHNAN; J B SELKON; P R SOMASUNDARAM
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

Review 3.  Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Proc R Soc Med       Date:  1977-01

4.  The diet, physical activity and accommodation of patients with quiescent pulmonary tuberculosis in a poor South Indian community. A four-year follow-up study.

Authors:  C V Ramakrishnan; K Rajendran; K Mohan; W Fox; S Radhakrishna
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

5.  Comparative value of sputum smear examination and culture examination in assessing the progress of tuberculous patients receiving chemotherapy.

Authors:  S Devadatta; S Radhakrishna; W Fox; D A Mitchison; S Rajagopalan; S Sivasubramanian; H Stott
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

6.  The scope of the controlled clinical trial, illustrated by studies of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.

Authors: 
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

8.  Influence of segregation to tuberculous patients for one year on the attack rate of tuberculosis in a 2-year period in close family contacts in South India.

Authors:  C V RAMAKRISHNAN; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; P R SOMASUNDARAM; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

9.  A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Authors:  J J Dawson; S Devadatta; W Fox; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S P Tripathy; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India.

Authors:  S R Kamat; J J Dawson; S Devadatta; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.